...
首页> 外文期刊>Current therapeutic research, clinical and experimental. >Correlation of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration in Han Chinese patients treated with azathioprine 25 to 100 mg: A 1-year, single-center, prospective study
【24h】

Correlation of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration in Han Chinese patients treated with azathioprine 25 to 100 mg: A 1-year, single-center, prospective study

机译:汉族硫唑嘌呤25-100 mg治疗的汉族患者中硫嘌呤甲基转移酶活性与6-硫鸟嘌呤核苷酸浓度的相关性:一项为期一年的单中心前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Of the enzymes involved in the metabolism of azathioprine, thiopurine methyltransferase (TPMT) is the one characterized by genetic polymorphisms and ethnic variations. There have been several studies of the ethnic variations in phenotype and genotype of TPMT, although few have assessed the possible correlation between TPMT activity and 6-thioguanine nucleotide (6-TGN) concentrations. Objective: The aim of this study was to examine the relationship between TPMT activity and the steady-state concentration (Css) of 6-TGN, the primary active metabolite of azathioprine, in red blood cells (RBCs) in Han Chinese patients treated with azathioprine. Methods: Han Chinese patients aged 18 to 60 years with immunosuppression and normal hepatic and renal function who had been receiving a stable dose (25-100 mg/d) of oral azathioprine as a part of their regular anti-immunosuppression regimen for at least 10 days were recruited for this 1-year, single-center, prospective study. Azathioprine was administered PO QD in the morning, in combination with a stable regimen of other immunosuppressive drugs, for 1 year. At 1 year, blood samples were drawn just before the ingestion of azathioprine. TPMT activity and 6-TGN Css in RBCs were determined in our laboratory using high-performance liquid chromatography. Adverse drug events were monitored by a patient questionnaire and laboratory testing. Out of the initial cohort, several patients were concurrently enrolled in a subanalysis in which the effect of TPMT polymorphism on the pharmacokinetic properties of 6-mercaptopurine, the intermediate metabolite of azathioprine, was examined. Results: Nineteen patients (14 women, 5 men; mean [SD] age, 41 [9.6] years [range, 22-59 years]; mean [SD] weight, 62 [12] kg) were included in the study; 7 were included in the subanalysis. A significant negative correlation was found between TPMT activity and 6-TGN Css in RBCs (r = -0.712; P = 0.001); when the outlier data were removed, no significant correlation was found. Mean (SD) TPMT activity was 12.95 (3.07) nmol/h · mL-1 RBCs and the interindividual CV was 23.68%. Mean (SD) 6-TGN CSS was 42.95 (41.98) ng/8 × 108 RBCs and the interindividual CV was 97.74% (N = 19), while the intraindividual CV of 6-TGNs within 8 hours after azathioprine ingestion was between 4.23% and 7.37% (n = 7). No significant correlation was found between 6-TGN Css in RBCs and the dose of azathioprine used. One patient's treatment was discontinued because her white blood cell count decreased to < 4 × 109 cells/L, indicating myelotoxicity; the t/12 of 6-TGNs in this patient was 5.85 days. Treatment was well tolerated by all other patients. Conclusion: In this small study, a significant negative correlation was found between TPMT activity and 6-TGN concentration in the RBCs of these Han Chinese patients. However, the correlation was not significant when data from 1 patient with low TPMT activity were excluded. 2006 Excerpta Medica, Inc.
机译:背景:在硫唑嘌呤代谢中涉及的酶中,硫嘌呤甲基转移酶(TPMT)是一种具有遗传多态性和种族差异的酶。关于TPMT的表型和基因型的种族差异,已经进行了几项研究,尽管很少有人评估TPMT活性与6-硫鸟嘌呤核苷酸(6-TGN)浓度之间的可能相关性。目的:本研究的目的是研究硫唑嘌呤治疗的汉族患者中红细胞(TPC活性)与硫唑嘌呤主要活性代谢物6-TGN的稳态浓度(Css)之间的关系。 。方法:18至60岁具有免疫抑制功能且肝和肾功能正常的汉族患者,已接受稳定剂量(25-100 mg / d)的口服硫唑嘌呤作为常规抗免疫抑制方案的一部分,至少接受10次这项为期1年的单中心前瞻性研究招募了3天。硫唑嘌呤于早晨口服QD,并与其他免疫抑制药物的稳定治疗方案联合使用1年。在第1年,就在摄入硫唑嘌呤之前抽取了血液样本。在我们的实验室中,使用高效液相色谱法测定了红细胞中的TPMT活性和6-TGN Css。通过患者问卷调查和实验室测试监测药物不良反应。在最初的队列中,同时进行了几例患者的亚组分析,其中分析了TPMT多态性对硫唑嘌呤的中间代谢物6-巯基嘌呤药代动力学特性的影响。结果:该研究纳入了19名患者(14名女性,5名男性;平均[SD]年龄:41 [9.6]岁[范围:22-59岁];平均[SD]体重:62 [12] kg)。子分析中包括7个。在RBC中,TPMT活性与6-TGN Css之间存在显着的负相关性(r = -0.712; P = 0.001)。当除去异常数据时,未发现显着相关性。 TPMT活性的平均值(SD)为12.95(3.07)nmol / h·mL-1 RBC,个体间CV为23.68%。摄入硫唑嘌呤后8小时内,6-TGN CSS的平均值(SD)为42.95(41.98)ng / 8×108 RBC,个体间CV为97.74%(N = 19),而6-TGNs的个体内CV为4.23%和7.37%(n = 7)。在RBC中的6-TGN Css与所用硫唑嘌呤的剂量之间未发现显着相关性。一名患者的治疗中断,因为她的白细胞计数降至<4×109细胞/ L,表明具有骨髓毒性。该患者的6-TGNs的t / 12为5.85天。所有其他患者对治疗的耐受性良好。结论:在这项小型研究中,这些汉族患者的RBC中TPMT活性与6-TGN浓度之间存在显着负相关。但是,当排除1名TPMT低活性患者的数据时,相关性不显着。 2006 Excerpta Medica,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号